Ionis Pharmaceuticals in (ions 0 04/01/26)
13F holders, Q4 2025 (December 31)10holders +3
5new positions
1sold out
$1.41avg. 13F price*
At the end of Q4 2025, 10 institutions reported holding Ionis Pharmaceuticals in (ions 0 04/01/26) in their 13F filings, up 3 from Q3 2025. 5 opened new positions and 1 sold out. The largest holders were Ovata Capital Management Ltd ($51.9M), Nomura Holdings Inc. ($1.4M) and BNP PARIBAS ASSET MANAGEMENT Holding S.A. ($685K).
- Company
- Ionis Pharmaceuticals in (ions 0 04/01/26)
- CUSIP
- 462222AD2
- Latest filing quarter
- Q4 2025
History
Number of 13F holders
Total Exit/New Position Q3 2025 → Q4 2025
| Institutions | Total Value | |
|---|---|---|
| New Positions | 5 | $53.5M |
| Exits | 1 | $6K |
All 13F filers, Q3 2025 → Q4 2025: 37,913,155 shares bought and 89,000 shares sold, net +37,824,155 shares. Counts holders who added, trimmed, opened or closed a position; split-adjusted.
Ownership 10 holders
| Ovata Capital Management Ltd | 6.30% | New | 37,723,000 | $51.9M |
| Nomura Holdings Inc. | 0.00% | New | 17,155 | $1.4M |
| BNP PARIBAS ASSET MANAGEMENT Holding S.A. | 0.00% | No change | 500,000 | $685K |
| Bank of New York Mellon Corp | 0.00% | Reduce -28.0% | 216,000 | $298K |
| Focus Partners Wealth | 0.00% | New | 160,000 | $219K |
| Oppenheimer Asset Management Inc. | 0.00% | No change | 95,000 | $130K |
| Stephens Inc. | 0.00% | No change | 26,000 | $36K |
| Traub Capital Management LLC | 0.02% | No change | 17,000 | $23K |
| MML Investors Services, LLC | 0.00% | New | 10,000 | $14K |
| CoreCap Advisors, LLC | 0.00% | New | 3,000 | $4K |
"% of holder's portfolio" is IONIS PHARMACEUTICALS IN (IONS 0 04/01/26)'s weight in each manager's 13F, not the share of Ionis Pharmaceuticals in (ions 0 04/01/26) the manager owns.